M. Saunders

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma

Youn H. Kim, Francine Foss, Jasmine Zain et al. · Blood · 2012 · 131 citations

Medicine, Oncology, Pharmacotherapy +11

Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Michael F. Robinson, Nemanja Damjanov, Bojana Stamenković et al. · Arthritis & Rheumatology · 2020 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Diaspirin-Crosslinked Hemoglobin Reduces Blood Transfusion in Noncardiac Surgery: A Multicenter, Randomized, Controlled, Double-Blinded Trial

Armin Schubert, Robert J. Przybelski, John F. Eidt et al. · Anesthesia & Analgesia · 2003 · 69 citations

Medicine, Perioperative Medicine, Surgery +17

The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.

M. Saunders, Stanley Dische, Peter J. Anderson et al. · PubMed · 1978 · 63 citations

Pharmacy, Neurology, Pharmacology +17

Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers

Elżbieta Izbicka, A. Díaz, Robert T. Streeper et al. · Cancer Chemotherapy and Pharmacology · 2009 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17